Ahmadinejad Period Islamic Republic of Iran: Relations with Hezbollah
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
The Hezbollah organization, which emerged in Lebanon, has been an important political and military actor in Lebanon and the Middle East since its inception. The Hezbollah organization, which was considered "terrorist" by some countries as both political and military, was influenced by a number of internal and external dynamics in the organization and growth phase. For a better understanding of the structure and impact power of the organization, these dynamics must be examined individually. In terms of external dynamics, Hezbollah has been in intense relations with Iran in both the founding phase and the following period. In this context, primarily the internal and external dynamics will be examined, and the Iranian relations, which are the ideological and political common denominators of the Organization, will be examined especially during the Ahmadinejad period (2005-2013). Key Words: Terrorism, Hezbollah, Iran, Ahmadinejad, Lebanon
Author
Yıldız Gözde Gürsel
Institution
How to Cite
Yıldız Gözde Gürsel (Master Thesis). Ahmadinejad Period Islamic Republic of Iran: Relations with Hezbollah, 2019, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)